Eko Analysis Software vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Eko Analysis Software
by Eko Health
VS
LINQ II Insertable Cardiac Monitor
by Medtronic

AI Verdict

Eko Analysis Software is a non-invasive, point-of-care AI tool for clinicians to aid in the early detection of heart murmurs and atrial fibrillation during auscultation. In contrast, the Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous, and remote monitoring to diagnose arrhythmias over extended periods. While both leverage AI in cardiology, Eko focuses on immediate clinical assessment, whereas LINQ II provides prolonged, passive monitoring for diagnostic purposes.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you are a clinician seeking an immediate, non-invasive AI-powered tool for early detection of cardiovascular diseases like heart murmurs and atrial fibrillation during routine examinations or remote patient monitoring. This tool is ideal for point-of-care screening, allowing for real-time auscultation, recording, and analysis of heart sounds and ECGs to inform timely clinical decisions.

View Eko Analysis Software →

Choose LINQ II Insertable Cardiac Monitor if…

Choose LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous, and passive heart rhythm monitoring to diagnose infrequent or elusive arrhythmias that may not be captured by external devices or intermittent clinic visits. This implantable solution offers up to 4.5 years of AI-powered monitoring with remote management capabilities, making it suitable for extended diagnostic periods.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software LINQ II Insertable Cardiac Monitor
Deployment Unknown Subcutaneous implant with remote monitoring via mobile app or home communicator.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software LINQ II Insertable Cardiac Monitor
Name Eko Analysis Software LINQ II Insertable Cardiac Monitor
Company Eko Devices Medtronic
Key AI-Powered Detection/Algorithm FDA-cleared AI for heart murmur detection; FDA-cleared AI for atrial fibrillation (AFib) detection; Detection of normal sinus rhythm; Calculation of cardiac time intervals AccuRhythmu2122 AI algorithms for enhanced accuracy; Innovative PVC detection algorithm
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology
Device Type/Integration Integrates with Eko's digital stethoscopes and mobile app; Wireless auscultation with Bluetooth-enabled devices Insertable cardiac monitor; MyCareLink Heartu2122 mobile app for data transmission; MyCareLink Relayu2122 home communicator option
Continuous Monitoring Duration Not specified Up to 4.5 years of continuous monitoring

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and LINQ II Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software is an FDA-cleared AI-powered tool that integrates with digital stethoscopes and a mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation during examinations. In contrast, the Medtronic LINQ II is an FDA-cleared, AI-powered insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias.
Eko Analysis Software is FDA-cleared for AI-powered detection of heart murmurs, atrial fibrillation (AFib), and normal sinus rhythm, and calculates cardiac time intervals. The LINQ II Insertable Cardiac Monitor, with its AccuRhythmu2122 AI algorithms, is designed for enhanced accuracy in detecting and diagnosing various arrhythmias, including reducing false AF and pause alerts, and features an innovative PVC detection algorithm.
Eko Analysis Software is used for point-of-care auscultation and recording of heart sounds and ECGs, with secure cloud-based storage for these recordings. The LINQ II Insertable Cardiac Monitor provides continuous heart rhythm monitoring for an extended period, up to 4.5 years, once implanted.
The LINQ II Insertable Cardiac Monitor is MRI compatible (1.5 and 3.0T) and has an FDA clearance for pediatric patients aged 2 years and older. Eko Analysis Software is FDA-cleared for use in both adult and pediatric patients for murmur detection, but does not list MRI compatibility as a feature.
Eko Analysis Software allows for recording, playback, and annotation of heart sounds and ECGs, with secure cloud-based storage of recordings within the US, and telehealth livestreaming requires a paid subscription. The LINQ II Insertable Cardiac Monitor facilitates data transmission via the MyCareLink Heartu2122 mobile app or the MyCareLink Relayu2122 home communicator option, and offers remote programming capability.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Eko Analysis Software or LINQ II Insertable Cardiac Monitor

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.